AHPBA Pancreatic Irreversible Electroporation (IRE) Registry for Pancreatic Cancer
University of Louisville
Summary
The purpose of this study is to create a registry to provide insight into treatment selection and treatment outcome of pancreatic IRE in order to develop an evidence base such that physicians can provide the best possible care to patients with pancreatic cancer requiring surgical interventions. The investigators seek a better understanding of the uses of ablation in the treatment of unresectable soft tissue pancreatic tumors and the limitations, concerns and complications that earlier users have.
Description
Rationale: The rationale for creating this multi-center clinical database is to optimally collect clinical and pathological data on patients with neoplasms in order to facilitate future clinical observational and outcomes-based research. Inclusion Criteria Patients will be considered eligible for inclusion into the database if they meet the following eligibility criteria: Evidence/suspicion of Pancreatic neoplasm ≥ 18 years of age Exclusion Criteria Patients will be considered ineligible for inclusion into the database if they are not able to give consent. Inclusion of Women, Minorities…
Eligibility
- Age range
- 18+ years
- Sex
- All
- Healthy volunteers
- No
Inclusion Criteria: * Adult patients (greater than 18 years of age) diagnosed with pancreatic cancer that are eligible for soft tissue ablation per the treating physician. Exclusion Criteria: * Have a cardiac pacemaker or ICD implant * Non-removable implants with metal parts near target lesion * Myocardial infarction within 3 months prior to enrollment * Not suitable for general endotracheal anesthesia
Interventions
- OtherRegistry
Locations (16)
- University of Alabama BirminghamBirmingham, Alabama
- University of California San DiegoSan Diego, California
- University of ColoradoDenver, Colorado
- University of South FloridaTampa, Florida
- Augusta UniversityAugusta, Georgia
- University of LouisvilleLouisville, Kentucky